Stay updated on Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial
Sign up to get notified when there's something new on the Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial page.

Latest updates to the Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial page
- Check5 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous study content and links. This indicates that access to the study details is currently restricted.SummaryDifference17%

- Check12 days agoChange DetectedTel Litwinsky, Israel has been added as a participating site, and Qiryat Krinitzi, Israel has been removed from the study locations. This captures the updated geographic footprint of enrolling sites for the trial.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedLocations are updated to include Qiryat Krinitzi, Israel and remove Tel Litwinsky, Israel. This reflects revision updates (v3.6.6 for the addition and v3.6.5 for the deletion).SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a new page revision.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a minor version update to the page without changing substantive content.SummaryDifference0.0%

- Check83 days agoChange DetectedThe revision label on the page was updated from v3.6.2 to v3.6.3. This indicates a newer revision of the page's documentation and assets rather than a change to user-visible content.SummaryDifference0.0%

Stay in the know with updates to Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial page.